Zymeworks Inc (ZYME)
8.94
-0.16
(-1.76%)
USD |
NASDAQ |
May 07, 10:43
Zymeworks Total Liabilities (Quarterly): 115.75M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 115.75M |
December 31, 2023 | 116.07M |
September 30, 2023 | 132.02M |
June 30, 2023 | 153.14M |
March 31, 2023 | 127.20M |
December 31, 2022 | 155.77M |
September 30, 2022 | 120.50M |
June 30, 2022 | 146.69M |
March 31, 2022 | 147.53M |
December 31, 2021 | 140.04M |
September 30, 2021 | 141.43M |
June 30, 2021 | 150.48M |
March 31, 2021 | 112.91M |
December 31, 2020 | 128.45M |
September 30, 2020 | 139.36M |
Date | Value |
---|---|
June 30, 2020 | 115.60M |
March 31, 2020 | 114.16M |
December 31, 2019 | 122.52M |
September 30, 2019 | 90.51M |
June 30, 2019 | 80.53M |
March 31, 2019 | 68.27M |
December 31, 2018 | 63.99M |
September 30, 2018 | 24.77M |
June 30, 2018 | 24.53M |
March 31, 2018 | 19.01M |
December 31, 2017 | 15.53M |
September 30, 2017 | 17.15M |
June 30, 2017 | 17.62M |
March 31, 2017 | 89.04M |
December 31, 2016 | 84.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
80.53M
Minimum
Jun 2019
155.77M
Maximum
Dec 2022
127.53M
Average
127.83M
Median
Total Liabilities (Quarterly) Benchmarks
Emergent BioSolutions Inc | 1.140B |
MariMed Inc | 126.21M |
Viemed Healthcare Inc | 41.00M |
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 553.75M |
Shareholders Equity (Quarterly) | 438.00M |
Current Ratio | 6.922 |